Salukhov V.V., Shustov S.B., Petrankov K.V.
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus
|
№8 / 2024
|
Shchemeleva E.V., Skorodumova E.A.
Febuxostat: Efficacy and safety of the drug, prospects for application (literature review)
|
№5 / 2024
|
Alieva A.M., Nikitin I.G., Teplova N.V., Baykova I.E., Rakhaev A.M., Kudaeva M.V., Sozaeva M.R., Kotikova I.A.
Diagnostic and therapeutic aspects of irisin in cardiovascular pathology and metabolic disorders
|
№9 / 2023
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening
|
№9 / 2023
|
Livzan M.A., Bikbavova G.R., Safiulina T.A., Loginova E.N.
Gut microbiome modulation and cardiovascular risks: Mechanisms of formation and correction
|
№8 / 2023
|
Ponomareva E.Yu., Sedov D.S.
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment
|
№4 / 2023
|
Reznik E.V., Golubev Yu.Yu., Zhuravlev A.K., Yurtaeva N.V., Ischenko G.Yu.
Arterial hypertension and longevity
|
№10 / 2022
|
Glibko K.V., Arakelov S.E., Titova I.Yu., Kasaeva D.A., Larina V.N.
Peculiarities of cardiovascular outcomes in male and female patients after novel coronavirus infection caused by SARS-CoV-2
|
№9 / 2022
|
Podorozhnyuk K.V., Skuridina D.V.
The importance of a multifactorial approach in the treatment of type 2 diabetes mellitus: clinical cases
|
№8 / 2022
|
Demidova T.Yu., Izmailova M.Ya.
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
|
№8 / 2022
|
Khlynova O.V., Stepina E.A., Trapeznikova A.A.
Inflammatory bowel diseases and cardiovascular pathology: pathogenetic correlations and age-related peculiarities
|
№7 / 2022
|
Alieva A.M., Teplova N.V., Ettinger O.A., Reznik E.V., Baykova I.E., Sarakaeva L.R., Shnahova L.M., Arakelyan R.A., Valiev R.K., Nikitin I.G.
The role of interleukin 12 in the development of cardiovascular diseases
|
№6 / 2022
|